SOLIRIS 300 mg/30mL
ECULIZUMAB · INJECTION, SOLUTION, CONCENTRATE · Alexion Pharmaceuticals Inc.
No Recall History
Plain English
SOLIRIS is a injection, solution, concentrate containing eculizumab at 300 mg/30mL, taken intravenous. Manufactured by Alexion Pharmaceuticals Inc..
Key Facts
- Brand Name
- SOLIRIS
- Generic Name
- ECULIZUMAB
- NDC Code (Product)
25682-001- Manufacturer
- Alexion Pharmaceuticals Inc.
- Strength
- 300 mg/30mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125166
- Drug Class
- Complement Inhibitor [EPC]
- Marketing Start
- 04/02/2007
Recall History
No Recall HistoryFrequently Asked Questions
What is SOLIRIS used for?
SOLIRIS contains ECULIZUMAB. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is SOLIRIS a controlled substance?
SOLIRIS is not classified as a controlled substance by the DEA.
What is the generic name for SOLIRIS?
The generic name for SOLIRIS is ECULIZUMAB. There are 2 other brand versions of ECULIZUMAB.
What is the NDC code for SOLIRIS 300 mg/30mL?
The NDC (National Drug Code) for SOLIRIS 300 mg/30mL is 25682-001, listed by Alexion Pharmaceuticals Inc..